Abstract
Current asthma therapy is aimed at controlling disease symptoms. A subset of asthma patients remains symptomatic despite optimal therapy indicating that an unmet medical need exists for these patients. Innovative therapeutics are needed to treat the unmet need in asthma and biopharmaceutical approaches may provide an opportunity for identifying these agents. It is proposed that airway remodeling contributes to asthma symptoms and this feature of disease pathology may be a target for future therapies. The current review focuses on the contribution of one feature of airway remodeling, subepithelial fibrosis, towards disease and highlights some of the mechanisms that may contribute to this feature of airway remodeling. Further, some potential molecular targets are identified for consideration for therapeutic intervention.
Keywords: Biopharmaceuticals, asthma, remodeling, unmet need
Current Pharmaceutical Design
Title: Biopharmaceutical Therapeutics for Asthma Remodeling
Volume: 12 Issue: 25
Author(s): A. M. Das, D. E. Griswold, T. J. Torphy and L. Li
Affiliation:
Keywords: Biopharmaceuticals, asthma, remodeling, unmet need
Abstract: Current asthma therapy is aimed at controlling disease symptoms. A subset of asthma patients remains symptomatic despite optimal therapy indicating that an unmet medical need exists for these patients. Innovative therapeutics are needed to treat the unmet need in asthma and biopharmaceutical approaches may provide an opportunity for identifying these agents. It is proposed that airway remodeling contributes to asthma symptoms and this feature of disease pathology may be a target for future therapies. The current review focuses on the contribution of one feature of airway remodeling, subepithelial fibrosis, towards disease and highlights some of the mechanisms that may contribute to this feature of airway remodeling. Further, some potential molecular targets are identified for consideration for therapeutic intervention.
Export Options
About this article
Cite this article as:
Das M. A., Griswold E. D., Torphy J. T. and Li L., Biopharmaceutical Therapeutics for Asthma Remodeling, Current Pharmaceutical Design 2006; 12 (25) . https://dx.doi.org/10.2174/138161206778194097
DOI https://dx.doi.org/10.2174/138161206778194097 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Airway Fibrosis and Angiogenesis due to Eosinophil Trafficking in Chronic Asthma
Current Molecular Medicine Concomitant Gene Mutations of MBL and CYBB in Chronic Granulomatous Disease: Implications for Host Defense
Inflammation & Allergy - Drug Targets (Discontinued) Caffeic Acid, A Versatile Pharmacophore: An Overview
Mini-Reviews in Medicinal Chemistry Adrenomedullin: Exciting New Horizons
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery Current Status of Anti-Picornavirus Therapies
Current Pharmaceutical Design Chemokines in Allergy
Current Drug Targets - Inflammation & Allergy Poly(ADP-Ribosylation): Beneficial Effects of Its Inhibition
Current Enzyme Inhibition Overview of Medicinally Important Diterpenoids Derived from Plastids
Mini-Reviews in Medicinal Chemistry Mouse Models of Asthma: Can They Give Us Mechanistic Insights into the Role of Nitric oxide?
Current Medicinal Chemistry Study of Anti-inflammatory Activity of a New Non-opioid Analgesic on the Basis of a Selective Inhibitor of TRPA1 Ion Channels
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Creating Chemical Diversity to Target Protein Kinases
Combinatorial Chemistry & High Throughput Screening Circulating MicroRNAs as a New Class of Biomarkers of Physiological Reactions of the Organism to the Intake of Dietary Supplements and Drugs
MicroRNA Adverse Drug Reactions in the Oral Cavity
Current Pharmaceutical Design A Discussion of Natural Rubber Latex Allergy with Special Reference to Children: Clinical Considerations
Current Drug Targets - Immune, Endocrine & Metabolic Disorders Classic Histamine H1 Receptor Antagonists: A Critical Review of their Metabolic and Pharmacokinetic Fate from a Birds Eye View
Current Drug Metabolism Identification and Quantification of MIDD0301 Metabolites
Current Drug Metabolism Current Status and Future Prospects for Research on Tyrosine Sulfation
Current Pharmaceutical Biotechnology Headache: One of the Most Common and Troublesome Adverse Reactions to Drugs
Current Drug Safety Editorial (Thematic Issue: Therapeutic Applications of Advanced Drug Delivery Systems)
Current Pharmaceutical Design Prophylaxis and Therapy of Allergy by Mucosal Tolerance Induction with Recombinant Allergens or Allergen Constructs
Current Drug Targets - Inflammation & Allergy